Smith, Moore & Co. Landec Corp \Ca\ Transaction History

Smith, Moore & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	N/A	12,000 New	12,000 $0
Q2 2022 Aug 12, 2022	SELL	$8.84 - $11.64 $4,420 - $5,820	-500 Reduced 4.55%	10,500 $105,000
Q1 2022 May 12, 2022	BUY	$10.07 - $11.93 $10,070 - $11,930	1,000 Added 10.0%	11,000 $127,000
Q4 2021 Feb 08, 2022	BUY	$7.95 - $11.24 $79,500 - $112,400	10,000 New	10,000 $111,000

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

Stay updated on Smith, Moore & Co. with notifications on news.